Metraipolis › archive › dc_cfca07eed299

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with… — Europe PMC PMID:41049829

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41049829
DOI: 10.3389/fonc.2025.1671529
License (as archived): solo-consultazione
Archived: 2026-11-09T21:25:46.684Z
SHA-256 of the archived text: b585a99df69f761eb4cc4469f4455fd6717317f3653b99608d8c4c66e60a2311
Stable URL of this page: https://metraipolis.com/documento/dc_cfca07eed299

How to cite

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with… — Europe PMC PMID:41049829 — Europe PMC (en), https://europepmc.org/article/MED/41049829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfca07eed299 (Metraipolis archive dc_cfca07eed299, sha256 b585a99df69f761eb4cc4469f4455fd6717317f3653b99608d8c4c66e60a2311)

BibTeX

@misc{dccfca07eed299,
  title = {Venetoclax as a cytoreduction therapy option for acute promyelocytic leukemia in newly diagnosed adult patients: a case report of a 35-year-old female with… — Europe PMC PMID:41049829},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41049829},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfca07eed299; sha256 b585a99df69f761eb4cc4469f4455fd6717317f3653b99608d8c4c66e60a2311},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41049829. Agents can read the archived copy with the MCP tool read_document.